May 7, 2020 / 12:31 PM / a month ago

BRIEF-Selecta Biosciences Q1 Loss Per Share $0.21

Selecta Biosciences Inc:

* SELECTA BIOSCIENCES REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.21

* Q1 EARNINGS PER SHARE ESTIMATE $-0.28 — REFINITIV IBES DATA

* SELECTA BIOSCIENCES - ONGOING COVID-19 PANDEMIC HAS NOT MATERIALLY IMPACTED COMPARE TRIAL PROGRESS

* SELECTA BIOSCIENCES - TOPLINE DATA ANNOUNCEMENT FROM ONGOING HEAD-TO-HEAD COMPARE TRIAL OF SEL-212 REMAINS ON SCHEDULE FOR Q3 2020

* SELECTA BIOSCIENCES - GENE THERAPY PROGRAM IN COLLABORATION WITH ASKBIO REMAINS ON TRACK TO ENTER CLINIC BY Q4 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below